Neuropilins as receptors for semaphorins

被引:0
|
作者
不详
机构
来源
NEUROSCIENTIST | 1999年 / 5卷 / 02期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:68 / 68
页数:1
相关论文
共 50 条
  • [31] Regulation of immune cell responses by semaphorins and their receptors
    Kumanogoh, Atsushi
    Takamatsu, Hyota
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [32] Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis
    Hu, Shuhong
    Zhu, Li
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [33] Regulation of immune cell responses by semaphorins and their receptors
    Hyota Takamatsu
    Tatsusada Okuno
    Atsushi Kumanogoh
    Cellular & Molecular Immunology, 2010, 7 : 83 - 88
  • [34] Regulation of immune cell responses by semaphorins and their receptors
    Takamatsu, Hyota
    Okuno, Tatsusada
    Kumanogoh, Atsushi
    CELLULAR & MOLECULAR IMMUNOLOGY, 2010, 7 (02) : 83 - 88
  • [35] Regulation of immune cell responses by semaphorins and their receptors
    Atsushi Kumanogoh
    Hyota Takamatsu
    Arthritis Research & Therapy, 14 (Suppl 1):
  • [36] The role of semaphorins and their receptors in vascular development and cancer
    Gu, Chenghua
    Giraudo, Enrico
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (09) : 1306 - 1316
  • [37] Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
    Liu, Dahai
    Li, Jie
    Qi, Fei
    You, Hua
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [38] Semaphorins and their receptors: Novel features of neural guidance molecules
    Kumanogoh, Atsushi
    Kikutani, Hitoshi
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2010, 86 (06): : 611 - 620
  • [39] Class 3 semaphorins and their receptors in physiological and pathological angiogenesis
    Staton, Carolyn A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1565 - 1570
  • [40] SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
    Valentini, Elisabetta
    Di Martile, Marta
    Del Bufalo, Donatella
    D'Aguanno, Simona
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)